Artículos científicos Open Access

PRINCIPLE: a community-based COVID-19 platform trial
The Lancet Respiratory Medicine
John Macleod, John Norrie
The impact of COVID-19 on hepatitis services and civil society organisations
The Lancet Gastroenterology & Hepatology
Chris Wingrove, et al
Tocilizumab in COVID-19 therapy: who benefits, and how?
The Lancet
Chengliang Yang, Hedi Zhao

Página 55 de 490

Síguenos en nuestras redes sociales

Suscríbete a nuestro Boletín Institucional
INSP logo
© 2022 INSP. Todos los derechos reservados.